Back to Search Start Over

Minimising risk in first-in-man trials

Authors :
Joris Hemelaar
Source :
Lancet (London, England). 369(9572)
Publication Year :
2007

Subjects

Subjects :
business.industry
Multiple Organ Failure
Medicine
Antibodies, Monoclonal
Humans
General Medicine
business
Antibodies, Monoclonal, Humanized
Risk Assessment
Randomized Controlled Trials as Topic

Details

ISSN :
1474547X
Volume :
369
Issue :
9572
Database :
OpenAIRE
Journal :
Lancet (London, England)
Accession number :
edsair.doi.dedup.....816dc0b0147c9a82eb2e90e26ca45ade

Tools

Authors Abstract Subjects Details